it means a number of sub groups hit it out of the ball park but for the whole trial it looks like there was a treatment effect size of 50% reduction in 20% more of the experimental patients than controls. as the primary was 50% more this has not met but I just don’t think it’s going to matter a jot at the end of the day. They were always going to do another trial with grun in Europe anyway and too much of this data is landmark that won’t be able to be ignored by the fda.
- Forums
- ASX - By Stock
- Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
it means a number of sub groups hit it out of the ball park but...
-
-
- There are more pages in this discussion • 1,003 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.00 |
Change
0.010(1.01%) |
Mkt cap ! $1.141B |
Open | High | Low | Value | Volume |
$1.01 | $1.01 | 94.3¢ | $8.618M | 8.821M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 43508 | $1.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 34138 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 43508 | 1.000 |
1 | 15862 | 0.995 |
5 | 58523 | 0.990 |
3 | 49529 | 0.985 |
3 | 53984 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.005 | 34138 | 2 |
1.010 | 59763 | 4 |
1.015 | 35684 | 2 |
1.020 | 77095 | 6 |
1.025 | 66956 | 6 |
Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online